Growth Capital Firm Profile
In the last 3 years, Ampersand Capital Partners has acquired 16 companies. It has also invested in 12 others.
Ampersand Capital Partners’ most common sectors for investment arelife science (52%) and medical products (21%) . The Firm’s most common investment types include growth capital (29%) and buyout (lbo, mbo, mbi) (28%). In total, Ampersand Capital Partners has invested in 25 US states and 11 different countries. Its largest (disclosed) acquisition occurred in 2024 when it acquired Avid Bioservices for $1.1B.
In the last 3 years, Ampersand Capital Partners has exited 14 companies. The Firm’s most common exit type is trade sale (70%). Ampersand Capital Partners’ largest (disclosed) exit occurred in 2008 when it sold Talecris Biotherapeutics Holdings Corp for $3.1B.
Join Mergr to view Ampersand Capital Partners’ full profile and discover more large growth capital firm investors just like it.
M&A Summary
-
M&A Total Activity138
- M&A Buy Activity83
- M&A Sell Activity55
- Total Sectors Invested 15
- Total Countries Invested 11
- M&A Buy/Sell Connections 64
- M&A Advisors 4